Together with companion legislation in the House, the Antibiotic Development to Advance Patient Treatment (ADAPT) Act , PATH would establish a streamlined approval pathway to help bring new antibacterial drugs to patients with highly resistant bacterial infections that are serious or life-threatening.
Diverse stakeholders are expressing support for this bipartisan legislation.
Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.
